Does perseris treat schizophrenia?

How does Perseris work for schizophrenia?

Perseris is an extended-release injectable form of risperidone. It provides steady levels of the antipsychotic for one month after a single subcutaneous injection. This mechanism blocks dopamine D2 and serotonin 5-HT2A receptors, which reduces the positive symptoms of schizophrenia such as hallucinations and delusions.

What clinical evidence supports its use?

Two short-term placebo-controlled trials showed statistically significant reductions in PANSS total scores compared with placebo. An open-label extension study demonstrated that most patients who responded to the initial dose maintained symptom control over 12 months. The FDA approved Perseris in 2018 based on these data.

How does Perseris compare with oral risperidone?

Perseris delivers the same active drug but removes daily pill burden and eliminates the need for daily adherence. Because it is injected, peak-to-trough fluctuations are smaller than with immediate-release tablets. Oral risperidone still offers faster dose titration and lower cost for patients who tolerate and remember daily dosing.

When does the Perseris patent expire?

The composition-of-matter patent listed for Perseris expires in 2031 according to DrugPatentWatch.com. Earlier formulation patents have already expired, opening the possibility for generic competition once the remaining exclusivity ends.

Can patients switch from other antipsychotics to Perseris?

Clinicians can transition stable patients from oral risperidone or other antipsychotics after a brief overlap period to ensure therapeutic coverage. Because Perseris reaches steady state after the first injection, prescribers often continue the prior oral antipsychotic for 1–2 weeks before stopping it.

What side effects do patients report most often?

The most common adverse reactions include injection-site pain, weight gain, and somnolence. Extrapyramidal symptoms and prolactin elevation occur at rates similar to oral risperidone. Long-term metabolic monitoring is recommended because of the risk of weight gain and lipid changes.

Are there cost or access considerations?

Perseris is available only through specialty pharmacies and requires administration by a health-care professional. Insurance coverage varies; some plans classify it as a medical benefit rather than a pharmacy benefit. Manufacturer copay assistance programs exist for eligible commercially insured patients.

[1] https://drugpatentwatch.com/drug/Perseris